Physician profile
Jeanne Eckert
NPI 1164411641
$1,820.82
in general payments reported to CMS, 2019-2025
18 companies · $77.24 in 2025
The $77.24 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $61.73 · 2022: $40.99 · 2023: $1,264 · 2024: $177 · 2025: $77.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,022 · Food and Beverage: $490 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,021.97 |
| Food and Beverage | $490.43 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,142.09 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $180.55 | 2023-2025 | Veozah |
| Pfizer INC. | $74.70 | 2019-2020 | |
| Hologic Sales and Service, LLC | $63.68 | 2019-2023 | Aptima, Myosure Tissue Removal Device, Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $60.82 | 2023-2025 | |
| Coopersurgical, INC. | $43.20 | 2022-2024 | Summit Doppler |
| Organon LLC | $39.28 | 2025 | Nexplanon |
| Osmotica Pharmaceutical Corp. | $35.00 | 2020 | |
| Therapeuticsmd, INC. | $34.67 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $28.70 | 2023-2024 | Myfembree |
| Abbvie INC. | $25.41 | 2019 | |
| Avion Pharmaceuticals | $21.99 | 2019 | |
| Duchesnay USA Incorporated | $14.44 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.24 | 2022 | |
| Vertical Pharmaceuticals, LLC | $13.29 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $12.05 | 2019 | |
| Mission Pharmacal Company | $10.92 | 2019 | |
| Channel Medsystems, INC. | $5.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Eckert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.